Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Importance of targeting post-prandial hyperglycaemia to achieve HbA1c goals in insulin glargine-treated subphenotypes of type 2 diabetes.

Diabetes, obesity & metabolism - 1 Jan 2026

Landgraf Wolfgang, Owens David R, Frier Brian M, Bolli Geremia B

Abstract excerpt

AIMS: To explore outcome parameters related to achieving HbA1c goal (<7.0%) in subphenotypes of type 2 diabetes (T2D), either on basal insulin (BI) glargine 300 U/mL or 100 U/mL or switched to these BIs (≥42 U/day) alone or with pre-prandial insulin. MATERIALS AND METHODS: Participants from three EDITION T2D trials (n = 2,435) were clustered into T2D subphenotypes, with ≥97% having either Severe Insulin-Deficient...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Blood Glucose

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 2

Share to Glycated Hemoglobin

Share to Hyperglycemia

Share to Hypoglycemic Agents

Share to Postprandial Period

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 41178705
DOI: 10.1111/dom.70231
PMCID: PMC12673423

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Importance of targeting post-prandial hyperglycaemia to achieve HbA1c goals in insulin glargine-treated subphenotypes of type 2 diabetes.PMID 41178705Read ↗

Personalized therapy algorithms for type 2 diabetes: a phenotype-based approachSemantic proximity Read ↗

Type 2 diabetes subphenotypes are associated with differential outcomes after metabolic and bariatric surgery: An international multicentre retrospective cohort study.Semantic proximity Read ↗

Efficacy and Safety Among Second-Generation and Other Basal Insulins in Adult Patients with Type 1 Diabetes: A Systematic Review and Network Meta-AnalysisSemantic proximity Read ↗

GLP1R Variants and Polygenic Risk Underlie Heterogeneous Response to GLP-1 Receptor Agonists in Type 2 DiabetesSemantic proximity Read ↗

A review of nateglinide in the management of patients with type 2 diabetes.Semantic proximity Read ↗

Phenotyping of type 2 diabetes mellitus at onset on the basis of fasting incretin tone: Results of a two-step cluster analysis.Semantic proximity Read ↗

Derivation and validation of a type 2 diabetes treatment selection algorithm for SGLT2-inhibitor and DPP4-inhibitor therapies based on glucose-lowering efficacy: cohort study using trial and routine clinical dataSemantic proximity Read ↗

Early identification of suboptimal responders to metformin in type 2 diabetes using long-term real-world HbA1c trajectoriesSemantic proximity Read ↗

Comparison of clustering and phenotyping approaches for subclassification of type 2 diabetes and its association with remission in Indian population.Semantic proximity Read ↗

Tirzepatide as Monotherapy Improved Markers of Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes (SURPASS-1)Semantic proximity Read ↗

Benefit of lifestyle-based T2DM prevention is influenced by prediabetes phenotype.Semantic proximity Read ↗

What is the best management strategy for patients with severe insulin resistance?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.